Cargando…
Jiedu-Yizhi Formula Improves Cognitive Impairment in an Aβ(25–35)-Induced Rat Model of Alzheimer's Disease by Inhibiting Pyroptosis
Jiedu-Yizhi formula (JDYZF) is prescribed for the treatment of Alzheimer's disease (AD) and was created by Jixue Ren, a master of traditional Chinese medicine, based on the “marrow deficiency and toxin damage” theory. In our clinic, this formula has been used for the treatment of AD for many ye...
Autores principales: | Wang, Jiale, Zhu, Xiaoting, Li, Yuhui, Zhang, Pengqi, Wang, Tianye, Li, Mingquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942661/ https://www.ncbi.nlm.nih.gov/pubmed/35341145 http://dx.doi.org/10.1155/2022/6091671 |
Ejemplares similares
-
Jiedu-Yizhi Formula Alleviates Neuroinflammation in AD Rats by Modulating the Gut Microbiota
por: Wang, Jiale, et al.
Publicado: (2022) -
Jiedu Yizhi Formula Improves Cognitive Function by Regulating the Gut Dysbiosis and TLR4/NF-κB Signaling Pathway
por: Zhang, Pengqi, et al.
Publicado: (2023) -
The Mechanisms of Bushen-Yizhi Formula as a Therapeutic Agent against Alzheimer’s Disease
por: Cai, Haobin, et al.
Publicado: (2018) -
Ethyl Acetate Extract Components of Bushen-Yizhi Formula Provides Neuroprotection against Scopolamine-induced Cognitive Impairment
por: Zhang, Shi-Jie, et al.
Publicado: (2017) -
Author Correction: Ethyl Acetate Extract Components of Bushen-Yizhi Formula Provides Neuroprotection against Scopolamine-induced Cognitive Impairment
por: Zhang, Shi-Jie, et al.
Publicado: (2020)